Metabolic Dysregulation and Cancer Risk: Coordinating Center for a national effort
Official title: Metabolic Dysregulation and Cancer Risk Program: Coordinating Center
Funded at George Washington University · NIH-11416292 · Data updated 2026-11-12
A national research program aims to understand how obesity-related metabolic problems influence cancer risk and help prevent cancer through shared measures and new discoveries.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | George Washington University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project start | September 20, 2022 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $849,209 |
| NIH project number | 5U24CA272450-05 |
| Project ID | NIH-11416292 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with obesity-related metabolic dysregulation who are at risk for obesity-linked cancers.
✕Less likely to help
People without obesity-related metabolic risk factors may derive little direct benefit.
What this research studies
This grant supports a coordinating center that brings together researchers studying how obesity-related metabolic dysregulation affects cancer initiation and progression. It focuses on creating common measures, linking key biological processes, and exploring new targets for cancer prevention. The work uses large-scale data, bioinformatics, and collaborative leadership to align methods across cancer types. Patients and the public may benefit indirectly through improved prevention strategies and insights from this consortium.
Why it matters
Potential benefit: If successful, the program could improve cancer prevention guidelines for people with obesity-related metabolic issues.
How similar studies have gone: Previous collaborative consortia have shown that harmonized measures can advance understanding of cancer risk related to metabolism.
Where this research is happening
-
George Washington University
Washington, United States Active
Researchers
- Principal investigator: Temprosa, Marinella — George Washington University
- Study coordinator: Temprosa, Marinella
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.